logo
Plus   Neg
Share
Email

Greencore Names Emma Hynes CFO, Effective May 19 - Quick Facts

Greencore Group plc (GNC.L), a manufacturer of convenience foods in the UK, announced Tuesday the appointment of Emma Hynes as Executive Director and Chief Financial Officer with effect from May 19. Hynes succeeds Eoin Tonge, who is leaving from Greencore in May 2020.

She will join Greencore as Chief Financial Officer Designate on April 6, 2020.

Hynes has been with Press Up Entertainment Group as Chief Financial Officer. Prior to joining Press Up Entertainment Group in 2019, she spent over 11 years with Greencore in a variety of finance leadership roles. Her most recent role at Greencore was Group Finance Director.

Patrick Coveney, CEO of Greencore Group said, "We are delighted that Emma is returning to Greencore having gained invaluable experience with an external company. Emma was an outstanding finance leader during her tenure with us and has an in-depth knowledge of both the Group and the food and beverage sector."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT